
Senator · AR · R
Current term Jan 3, 2023 – Jan 3, 2029 · In the Senate since Jan 5, 2011
Official websiteContact formBiographical Directory
Portrait: U.S. Government Publishing Office, via unitedstates/images (public domain)
Lobbying reports (LD-2) whose issue descriptions explicitly cite a bill this member sponsored, cosponsored, or cast a recorded vote on. This documents an overlap in subject only. LD-2 reports generally do not name the members contacted, and a citation does not show contact with this member, influence, or the client's position on the bill. No matching record means none was found within coverage, not that no lobbying occurred.
Loading lobbying reportsCoverage: LD-2 reports for 2025 onward, posted Jan 1, 2025 through Oct 25, 2026. Only the current version of each report is used.
39,758 report citations, newest first.
ADVION (FORMERLY NATIONAL ASSOCIATION FOR THE SUPPORT OF LONG TERM CARE) · lobbying firm or registrant: SIMS STRATEGIES, LLC
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 21, 2026 · issue area: Medicare/Medicaid
$50,000
Paid to lobbying firm
CitesS. 1816· this member:Cosponsored
…of 2025. H.R. 1614, To amend title XVIII of the Social Security Act to expand practitioners eligible to furnish telehealth services under the Medicare program. S. 1816/H.R. 3514, Improving Seniors' Timely Access to Care Act. H.R. 9693, the Patients First Act. H.R. 9844, the Connecting Health and Records Technology for Seniors…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
PROJECT ON GOVERNMENT OVERSIGHT · lobbying firm or registrant: PROJECT ON GOVERNMENT OVERSIGHT
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 21, 2026 · issue area: Government Issues
$10,000
Spent on own lobbying
CitesH.R. 7008· this member:Recorded vote on 1 roll call
…nsactions (HONEST) Act (S 1498) Supported the Ending Trading and Holdings In Congressional Stocks (ETHICS) Act (S 1171) Supported the Stop Insider Trading Act (HR 7008) Supported the FTC Whistleblower Act (H.R. 10792)
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
CREIGHTON UNIVERSITY · lobbying firm or registrant: SIMS STRATEGIES, LLC
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 21, 2026 · issue area: Education
$30,000
Paid to lobbying firm
CitesH.R. 1· this member:Recorded votes on 44 roll calls
Issues related to higher education. Issues related to implementation of higher education provisions within H.R. 1, including provisions related to student loans (P.L. 119-21). H.R. 6718, Professional Student Degree Act.
Congress inferred from the report year; bill number matches Congress.gov records and the bill predates the report; no title was cited with it. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
VISA, INC. · lobbying firm or registrant: 535 GROUP, LLC
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 21, 2026 · issue area: Financial Institutions/Investments/Securities
$50,000
Paid to lobbying firm
CitesH.R. 3633· this member:Recorded vote on 1 roll call
H.R. 3633, Digital Asset Market Clarity Act of 2025 H.R. 7035 and S. 3623 CCCA
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
ACADEMY OF ADOPTION AND ASSISTED REPRODUCTION ATTORNEYS (FKA AM AC ADPT ATTNYS) · lobbying firm or registrant: SIMS STRATEGIES, LLC
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 21, 2026 · issue area: Taxation/Internal Revenue Code
$20,000
Paid to lobbying firm
CitesH.R. 1· this member:Recorded votes on 44 roll calls
S. 1458/H.R. 2833, the Adoption Tax Credit Refundability Act of 2025. Implementation of Adoption Tax Credit provision in Sec. 70402 of H.R. 1 (P.L. 119-21).
Congress inferred from the report year; bill number matches Congress.gov records and the bill predates the report; no title was cited with it. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
POWER & COMMUNICATION CONTRACTORS ASSOCIATION · lobbying firm or registrant: GOVERNMENT AFFAIRS SOLUTIONS, LLC
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 21, 2026 · issue area: Labor Issues/Antitrust/Workplace
$50,000
Paid to lobbying firm
CitesS. 2984· this member:Cosponsored
…orker Protection Act (S.2613/H.R.4896.) Support for Senate HELP Committee legislative labor reforms, in general. Support for the Employee Rights Act (H.R. 4154/S. 2984). Support for the Start Applying Labor Transparency Act (H.R. 2952) Support for the Save Local Business Act (H.R. 4366) Concerns with joint employer issues, in…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
POWER & COMMUNICATION CONTRACTORS ASSOCIATION · lobbying firm or registrant: GOVERNMENT AFFAIRS SOLUTIONS, LLC
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 21, 2026 · issue area: Government Issues
$50,000
Paid to lobbying firm
CitesS. 100· this member:Cosponsored
Support for the Prove it Act of 2025 (H.R. 425/S. 100). Education about and comments regarding OMB Proposed Rule, Regulation for Federal Financial Assistance (91 FR 32198, Docket No. OMB-2026-0034)
Congress inferred from the report year; bill number matches Congress.gov records and the bill predates the report; no title was cited with it. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
BIOTECHNOLOGY INNOVATION ORGANIZATION · lobbying firm or registrant: BIOTECHNOLOGY INNOVATION ORGANIZATION
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 21, 2026 · issue area: Copyright/Patent/Trademark
$2,560,000
Spent on own lobbying
CitesS. 527· this member:Cosponsored
…ating Thickets to Increase Competition (ETHIC) Act ---H.R.9142: Prohibiting Adversarial Patents Act of 2026 ---S.43/H.R.6485: Skinny Labels, Big Savings Act ---S.527: Prescription Pricing for the People Act ---S.1041: Affordable Prescriptions for Patients Act ---S.1095: Stop STALLING Act ---S.1096: Preserve Access to Afford…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
BIOTECHNOLOGY INNOVATION ORGANIZATION · lobbying firm or registrant: BIOTECHNOLOGY INNOVATION ORGANIZATION
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 21, 2026 · issue area: Health Issues
$2,560,000
Spent on own lobbying
CitesS. 2903· this member:Cosponsored
…9: Priority for Pediatric Cures Act ---S.822: Scientific EXPERT Act ---Rare Disease Pilot Program Reimbursement and Coverage of Innovative Products ---H.R.5509/S.2903:SAFE STEP Act ---S.864/H.R.6423: HELP Copays Act ---Access to Innovative Treatments ---CMMI Authority ---Implementation of the Inflation Reduction Act (IRA) of…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
BIOTECHNOLOGY INNOVATION ORGANIZATION · lobbying firm or registrant: BIOTECHNOLOGY INNOVATION ORGANIZATION
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 21, 2026 · issue area: Health Issues
$2,560,000
Spent on own lobbying
CitesS. 5244· this member:Cosponsored
…Compensation Program 340B Drug Discount Program ---H.R.5256: 340B ACCESS Act ---H.R.9504: Tax Exempt Hospital Transparency Act ---H.R.9599: SECURE 340B Act ---S.5244: SUSTAIN 340B Act ---Program Implementation & Oversight ---Rebate Models Accelerated Approval Artificial Intelligence (AI) Alternative Funding Programs Biodefe…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
BIOTECHNOLOGY INNOVATION ORGANIZATION · lobbying firm or registrant: BIOTECHNOLOGY INNOVATION ORGANIZATION
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 21, 2026 · issue area: Health Issues
$2,560,000
Spent on own lobbying
CitesS. 526· this member:Cosponsored
…ovation (MINI) Act ---H.R.5391/S.2764 Protecting Patient Access to Cancer and Complex Therapies Act ---H.R.9418: Access to Innovative Treatments Act of 2026 ---S.526: Pharmacy Benefit Manager Transparency Act ---S.1097: Interagency Patent Coordination and Improvement Act ---S.1954: Biosimilar Red Tape Elimination Act ---S.3…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
BIOTECHNOLOGY INNOVATION ORGANIZATION · lobbying firm or registrant: BIOTECHNOLOGY INNOVATION ORGANIZATION
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 21, 2026 · issue area: Health Issues
$2,560,000
Spent on own lobbying
CitesS. 527· this member:Cosponsored
…nd Traceability Drug Patenting ---H.R.3269/S.2276: Eliminating Thickets to Increase Competition (ETHIC) Act ---S.43/H.R.6485: Skinny Labels, Big Savings Act ---S.527: Prescription Pricing for the People Act ---S.1041: Affordable Prescriptions for Patients Act ---S.1095: Stop STALLING Act ---S.1096: Preserve Access to Afford…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
BIOTECHNOLOGY INNOVATION ORGANIZATION · lobbying firm or registrant: BIOTECHNOLOGY INNOVATION ORGANIZATION
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 21, 2026 · issue area: Health Issues
$2,560,000
Spent on own lobbying
CitesS. 864· this member:Cosponsored
…c Cures Act ---S.822: Scientific EXPERT Act ---Rare Disease Pilot Program Reimbursement and Coverage of Innovative Products ---H.R.5509/S.2903:SAFE STEP Act ---S.864/H.R.6423: HELP Copays Act ---Access to Innovative Treatments ---CMMI Authority ---Implementation of the Inflation Reduction Act (IRA) of 2022 ---Medicare Part…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
BIOTECHNOLOGY INNOVATION ORGANIZATION · lobbying firm or registrant: BIOTECHNOLOGY INNOVATION ORGANIZATION
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 21, 2026 · issue area: Medicare/Medicaid
$2,560,000
Spent on own lobbying
CitesS. 5244· this member:Cosponsored
…d Infectious Diseases 340B Drug Discount Program ---H.R.5256: 340B ACCESS Act ---H.R.9504: Tax Exempt Hospital Transparency Act ---H.R.9599: SECURE 340B Act ---S.5244: SUSTAIN 340B Act ---Program Implementation & Oversight ---Rebate Models Accelerated Approval Artificial Intelligence (AI) Alternative Funding Programs Biosimi…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
BIOTECHNOLOGY INNOVATION ORGANIZATION · lobbying firm or registrant: BIOTECHNOLOGY INNOVATION ORGANIZATION
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 21, 2026 · issue area: Medicare/Medicaid
$2,560,000
Spent on own lobbying
CitesS. 526· this member:Cosponsored
…to Innovative Cures (EPIC) Act ---H.R.1672: Maintaining Investments and New Innovation (MINI) Act ---H.R.6166: Lowering Drug Costs for American Families Act ---S.526: Pharmacy Benefit Manager Transparency Act ---S.527: Prescription Pricing for the People Act ---S.1096: Preserve Access to Affordable Generics and Biosimilars…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
BIOTECHNOLOGY INNOVATION ORGANIZATION · lobbying firm or registrant: BIOTECHNOLOGY INNOVATION ORGANIZATION
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 21, 2026 · issue area: Medicare/Medicaid
$2,560,000
Spent on own lobbying
CitesS. 527· this member:Cosponsored
…cturing ---Compounded Medicines ---Drug Shortages ---Supply Chain Integrity and Traceability Drug Patenting ---S.43/H.R.6485: Skinny Labels, Big Savings Act ---S.527: Prescription Pricing for the People Act ---S.1095: Stop STALLING Act ---S.1096: Preserve Access to Affordable Generics and Biosimilars Act ---S.1097: Interage…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
BIOTECHNOLOGY INNOVATION ORGANIZATION · lobbying firm or registrant: BIOTECHNOLOGY INNOVATION ORGANIZATION
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 21, 2026 · issue area: Medicare/Medicaid
$2,560,000
Spent on own lobbying
CitesS. 864· this member:Cosponsored
…termeasures ---WHO Pandemic Preparedness Accord Reimbursement and Coverage of Innovative Products ---H.R.6166: Lowering Drug Costs for American Families Act ---S.864/H.R.6423: HELP Copays Act ---CMMI Authority ---Medicare Part B Physician-Administered Products ---National Coverage Determination ---Patient Cost-Sharing and S…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
BIOTECHNOLOGY INNOVATION ORGANIZATION · lobbying firm or registrant: BIOTECHNOLOGY INNOVATION ORGANIZATION
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 21, 2026 · issue area: Taxation/Internal Revenue Code
$2,560,000
Spent on own lobbying
CitesH.R. 1· this member:Recorded votes on 44 roll calls
…Orphan Drug Issues ---H.R.1414: Cameron's Law ---H.R.10359: Priority for Pediatric Cures Act Pandemic Preparedness Research & Development Tax Credit Reforms ---H.R.1: One Big Beautiful Bill Act ---H.R.1414: Cameron's Law ---Expensing of R&D Expenditures Vaccines and Infectious Disease ---H.R.9672: Vaccine Injury Compensatio…
Congress inferred from the report year; bill number matches Congress.gov records and the bill predates the report; no title was cited with it. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
NATIONAL TOUR ASSOCIATION · lobbying firm or registrant: ELEVATE GOVERNMENT AFFAIRS, LLC
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 21, 2026 · issue area: Real Estate/Land Use/Conservation
$10,000
Paid to lobbying firm
CitesS. 1547· this member:Cosponsored
…(P.L. 116-152), issues related to commercial use authorizations. The One Big Beautiful Bill Act (P.L. 119-21). Issues related to the America the Beautiful Act (S.1547), Issues related to the Great American Outdoors Act 250 (H.R.9250).
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
LINCOLN NATIONAL CORPORATION · lobbying firm or registrant: LINCOLN NATIONAL CORPORATION
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 21, 2026 · issue area: Taxation/Internal Revenue Code
$240,000
Spent on own lobbying
CitesH.R. 1· this member:Recorded votes on 44 roll calls
HR 1 / PL 119-21 One Big Beautiful Bill Act. HR 2547/S 1335 Secure Family Futures Act. Issue: debt investment tax change from capital to ordinary. Public Law 117-16…
Congress inferred from the report year; bill number matches Congress.gov records and the bill predates the report; no title was cited with it. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
MAJOR LEAGUE SOCCER PLAYERS ASSOCIATION · lobbying firm or registrant: ELEVATE GOVERNMENT AFFAIRS, LLC
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 21, 2026 · issue area: Labor Issues/Antitrust/Workplace
$10,000
Paid to lobbying firm
CitesS. 4668· this member:Recorded votes on 11 roll calls
…ights and Endorsements (SCORE) Act (H.R.4312). Issues related to the College Athletics Reform Act (H.R.6350). Issues related to the Protect College Sports Act (S. 4668; H.R. 9137).
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
NATIONAL HOCKEY LEAGUE PLAYERS ASSOCIATION · lobbying firm or registrant: ELEVATE GOVERNMENT AFFAIRS, LLC
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 21, 2026 · issue area: Labor Issues/Antitrust/Workplace
$10,000
Paid to lobbying firm
CitesS. 4668· this member:Recorded votes on 11 roll calls
…ights and Endorsements (SCORE) Act (H.R.4312). Issues related to the College Athletics Reform Act (H.R.6350). Issues related to the Protect College Sports Act (S. 4668; H.R. 9137).
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
NATIONAL FOOTBALL LEAGUE PLAYERS ASSOCIATION · lobbying firm or registrant: ELEVATE GOVERNMENT AFFAIRS, LLC
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 21, 2026 · issue area: Labor Issues/Antitrust/Workplace
$10,000
Paid to lobbying firm
CitesS. 4668· this member:Recorded votes on 11 roll calls
…ights and Endorsements (SCORE) Act (H.R.4312). Issues related to the College Athletics Reform Act (H.R.6350). Issues related to the Protect College Sports Act (S. 4668; H.R. 9137).
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
NATIONAL BASKETBALL PLAYERS ASSOCIATION · lobbying firm or registrant: ELEVATE GOVERNMENT AFFAIRS, LLC
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · amended · posted Oct 21, 2026 · issue area: Labor Issues/Antitrust/Workplace
$10,000
Paid to lobbying firm
CitesS. 4668· this member:Recorded votes on 11 roll calls
…ights and Endorsements (SCORE) Act (H.R.4312). Issues related to the College Athletics Reform Act (H.R.6350). Issues related to the Protect College Sports Act (S. 4668; H.R. 9137).
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
AMERICAN PIPELINE CONTRACTORS ASSOCIATION · lobbying firm or registrant: GOVERNMENT AFFAIRS SOLUTIONS, LLC
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 21, 2026 · issue area: Labor Issues/Antitrust/Workplace
$80,000
Paid to lobbying firm
CitesS. 2984· this member:Cosponsored
…orker Protection Act (S.2613/H.R.4896.) Support for Senate HELP Committee legislative labor reforms, in general. Support for the Employee Rights Act (H.R. 4154/S. 2984). Support for the Start Applying Labor Transparency Act (H.R. 2952) Support for the Save Local Business Act (H.R. 4366) Concerns with joint employer issues, in…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing